Skip to main content
Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · IEX Real-Time Price · USD
3.370
0.00 (0.00%)
May 2, 2024, 3:59 PM EDT - Market closed

Mersana Therapeutics Revenue

In the year 2023, Mersana Therapeutics had annual revenue of $36.86M with 38.65% growth. Revenue in the quarter ending December 31, 2023 was $10.70M, a -27.14% decrease year-over-year.

Revenue (ttm)
$36.86M
Revenue Growth
+38.65%
P/S Ratio
10.68
Revenue / Employee
$299,634
Employees
123
Market Cap
405.16M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.86M10.27M38.65%
Dec 31, 202226.58M26.54M61,716.28%
Dec 31, 202143.00K-785.00K-94.81%
Dec 31, 2020828.00K-41.30M-98.03%
Dec 31, 201942.12M31.53M297.61%
Dec 31, 201810.59M-6.95M-39.62%
Dec 31, 201717.55M-7.63M-30.30%
Dec 31, 201625.17M14.81M142.99%
Dec 31, 201510.36M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nevro 425.17M
OraSure Technologies 405.47M
Anika Therapeutics 166.66M
NeuroPace 65.42M
Cartesian Therapeutics 26.00M
Lexicon Pharmaceuticals 1.20M
Revenue Rankings

MRSN News

More News